X4 Pharmaceuticals, Inc.
XFOR
$3.57
$0.061.71%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 207.97M | 233.72M | 253.00M | 122.19M | 62.95M |
| Total Receivables | 2.05M | 1.11M | 573.00K | 1.61M | 1.87M |
| Inventory | 5.50M | 4.64M | 4.48M | 4.08M | 3.17M |
| Prepaid Expenses | 2.76M | 1.93M | 2.52M | 4.70M | 4.96M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 579.00K | 579.00K | 1.00M | 224.00K | -- |
| Total Current Assets | 218.86M | 241.98M | 261.58M | 132.81M | 72.94M |
|
|
|||||
| Total Current Assets | 218.86M | 241.98M | 261.58M | 132.81M | 72.94M |
| Net Property, Plant & Equipment | 765.00K | 1.18M | 1.59M | 1.99M | 2.90M |
| Long-term Investments | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Goodwill | 17.35M | 17.35M | 17.35M | 17.35M | 17.35M |
| Total Other Intangibles | 13.10M | 9.06M | 9.25M | 9.44M | 9.63M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.99M | 704.00K | 692.00K | 1.97M | 2.35M |
| Total Assets | 253.06M | 270.28M | 290.46M | 163.56M | 105.17M |
|
|
|||||
| Total Accounts Payable | 3.93M | 5.07M | 5.70M | 5.05M | 7.71M |
| Total Accrued Expenses | 14.13M | 17.06M | 18.60M | 16.44M | 13.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 465.00K | 733.00K | 994.00K | 1.20M | 1.37M |
| Total Finance Division Other Current Liabilities | 842.00K | 910.00K | 464.00K | 814.00K | 754.00K |
| Total Other Current Liabilities | 842.00K | 910.00K | 464.00K | 814.00K | 754.00K |
| Total Current Liabilities | 19.37M | 23.77M | 25.76M | 23.51M | 22.90M |
|
|
|||||
| Total Current Liabilities | 19.37M | 23.77M | 25.76M | 23.51M | 22.90M |
| Long-Term Debt | 76.76M | 76.52M | 76.29M | 76.06M | 75.84M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 95.00K | 815.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.48M | 1.54M | 2.12M | 2.27M | 1.65M |
| Total Liabilities | 97.61M | 101.83M | 104.17M | 101.94M | 101.20M |
|
|
|||||
| Common Stock & APIC | 786.53M | 783.37M | 780.95M | 632.37M | 544.92M |
| Retained Earnings | -630.95M | -614.80M | -594.55M | -570.63M | -540.81M |
| Treasury Stock & Other | -123.00K | -122.00K | -109.00K | -118.00K | -138.00K |
| Total Common Equity | 155.45M | 168.45M | 186.29M | 61.62M | 3.97M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 155.45M | 168.45M | 186.29M | 61.62M | 3.97M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 155.45M | 168.45M | 186.29M | 61.62M | 3.97M |
|
|
|||||